clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Update Preferences
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
Coronavirus
Mini Lungs Reveal More Cells Susceptible to COVID-19
News & Features
Antimicrobial Susceptibility Test Turnaround Time Slashed by Novel Method
News & Features
New Therapeutic Target Found for Acute Myeloid Leukemia
News & Features
Fecal Microbiota Transplants Could Boost Cancer Immunotherapy Efficacy
News & Features
New Research Shows Potential for Ketone Therapy in Heart Failure
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
Singlera Genomics Raises $150 Million in Series B Financing
Cancer screening
Molecular Dx
Singlera Genomics Raises $150 Million in Series B Financing
Chris Anderson
-
December 15, 2020
0
News & Features
Rare Mutation Confers Higher Multiple Cancer Risk for Ashkenazi Jews
Inside Precision Medicine Staff Writer
-
July 17, 2020
0
Molecular Dx
NIH-Developed Blood Test Improves Liver Cancer Screening
Chris Anderson
-
June 12, 2020
0
News & Features
Prescient Metabiomics, Harvard to Collaborate on Colon Cancer Screening Research
Chris Anderson
-
June 5, 2020
0
News & Features
Remote Screening Test for Ovarian Cancer Receives Study Validation
Chris Anderson
-
June 2, 2020
0
Molecular Dx
Combining CRISPR and Nanopore Sequencing Could Change Face of Cancer Diagnostics
Inside Precision Medicine Staff Writer
-
February 25, 2020
0
Molecular Dx
Personal Genome Diagnostics to Develop LBx to Inform Eisai Drug Discovery Efforts
Chris Anderson
-
January 16, 2020
0
Molecular Dx
ctDNA Methylation Profiles Power Effective Colorectal Cancer Diagnosis, Prognosis, and Screening
Chris Anderson
-
January 3, 2020
0
News & Features
Center for Community Engagement and Health Equity Launched by Yale Cancer Center
Chris Anderson
-
December 31, 2019
0
News & Features
Residual Cancer Burden (RCB) Predicts Breast Cancer Survival
Malorye Branca
-
December 13, 2019
0
1
...
11
12
13
14
Page 12 of 14
Related Content
New Therapeutic Target Found for Acute Myeloid Leukemia
Eliminating Disparity in Colonoscopy Follow-Up, Would Reduce Colon Cancer Death Rate
Study Finds Higher Rates of Hereditary Cancer Mutations in Minority Populations Missed by Current Screening Guidelines
Breast Cancer Survivors Are Undertested, But Share Gene Test Results
Inside Precision Medicine
![CRISPR Therapeutics and Massachusetts General Hospital Cancer Center said they will use CRISPR/Cas9 gene editing to develop novel T cell therapies for blood and solid tumors. [Source: Feng Zhang and Steve Dixo]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/1218.jpeg "Combining CRISPR and Nanopore Sequencing Could Change Face of Cancer Diagnostics")
